Panbela schedules conference call on march 24, 2022, to report 2021 fourth quarter financial results

Minneapolis, march 08, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that it will host a conference call on march 24, 2022 at 4:30 pm eastern time to discuss results for its fourth quarter ended december 31, 2021.
PBLA Ratings Summary
PBLA Quant Ranking